Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|April 20, 2018
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional PerspectiveWalaa Darwiche, Brigitte Gubler, Jean-Pierre Marolleau, et al.The Journal of Biological Chemistry|October 21, 2004
Calreticulin promotes folding of functional human leukocyte antigen class I molecules in vitroSlobodan Culina, Grégoire Lauvau, Brigitte Gubler, et al.Electrophoresis|March 25, 2009
Molecular identity of skin and blood T-cell clones in cutaneous T-cell lymphoma patients as determined from the migration pattern of the T-cell receptor-gamma gene by capillary electrophoresisBrigitte Gubler, Sophie Marty-Grès, Bernard Guillot, et al.Plos One|April 5, 2013
A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitroHussein Ghamlouch, Hakim Ouled-Haddou, Gandhi Damaj, et al.Frontiers in Immunology|January 14, 2017
The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple MyelomaStéphanie Trudel, Hussein Ghamlouch, Julie Dremaux, et al.Cytometry. Part B, Clinical Cytometry|April 16, 2025
Detection of circulating tumor cells is achieved by flow cytometry in melanoma patientsLudivine Fourdrain, Théo Brochet, Valentin Clichet, et al.Journal of Neuroscience Research|October 22, 2014
Oxidative stress is independent of inflammation in the neurodegenerative Sanfilippo syndrome type BStéphanie Trudel, Eric Trécherel, Cathy Gomila, et al.Immunology|October 19, 2013
Characterization of a new V gene replacement in the absence of activation-induced cytidine deaminase and its contribution to human B-cell receptor diversityHakim Ouled-Haddou, Hussein Ghamlouch, Aline Regnier, et al.AIDS (London, England)|September 10, 2002
In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specificAudrey Demoustier, Brigitte Gubler, Olivier Lambotte, et al.BMC Cancer|October 1, 2014
The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanomaStéphanie Trudel, Norbert Odolczyk, Julie Dremaux, et al.Pageof 2